Live feed
Filing
SC 13G/A
SC 13G/A0000902664-24-006526·Avoro Capital Advisors LLC
Schedule 13G ownership disclosure
Spyre Therapeutics Inc
Security class unavailable · CUSIP: 00773J202
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 885,059
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-006526
- Form type
- SC 13G/A
- Filer
- Avoro Capital Advisors LLC
- CIK
- CIK 1633313
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership